Key result
Homocysteine promotes neutrophil endothelial adhesion and transmigration, driving endothelial injury in translational models.
Despite intense investigation, mechanisms linking the development of occlusive vascular disease with elevated levels of homocysteine (HCY) are still unclear. The vascular endothelium plays a key role in regulating thrombogenesis and thrombolysis. We hypothesized that vascular lesions in individuals with elevated plasma HCY may be related to a dysfunction of the endothelium triggered by HCY. We investigated the effect of HCY on human neutrophil adhesion to and migration through endothelial monolayers. We also examined the effect of HCY on leukocyte adhesion and migration in mesenteric venules of anesthetized rats. We found that pathophysiological concentrations of HCY in vitro induce increased adhesion between neutrophils and endothelial cells. This contact results in neutrophil migration across the endothelial layer, with concurrent damage and detachment of endothelial cells. In vivo, HCY infused in anesthetized rats caused parallel effects, increasing leukocyte adhesion to and extravasation from mesenteric venules. Our results suggest that extracellular H2O2, generated by adherent neutrophils and/or endothelial cells, is involved in the in vitro endothelial cell damage. The possibility exists that leukocyte-mediated changes in endothelial integrity and function may lead to the vascular disease seen in individuals with elevated plasma HCY.
No takes yet. Share an insight, caveat, or question.
Dudman et al. (1999) studied Occlusive vascular disease mechanisms. Homocysteine (HCY) was evaluated on Neutrophil/leukocyte adhesion, migration, and endothelial cell damage. Pathophysiological concentrations of homocysteine increased neutrophil adhesion to and migration across the endothelium, resulting in endothelial damage in human cell cultures and rat models.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: